Clinical Trial Update: Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars [Phase 2]

View source ↗

Summary

A Phase 2 pilot safety and efficacy study of Isolagen Therapy for restrictive burn scar contractures in the joints was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burn Scar Contracture

Drugs mentioned

• Isolagen Therapy (autologous fibroblast therapy)

Snippet

Sponsor: Castle Creek Biosciences, LLC. | Conditions: Restrictive Burn Scars of Joint Area | Phase 2 | Status: WITHDRAWN